NO178542C - Benzo[fÅkinolinoner, farmasöytisk formulering og salt derav - Google Patents
Benzo[fÅkinolinoner, farmasöytisk formulering og salt deravInfo
- Publication number
- NO178542C NO178542C NO923265A NO923265A NO178542C NO 178542 C NO178542 C NO 178542C NO 923265 A NO923265 A NO 923265A NO 923265 A NO923265 A NO 923265A NO 178542 C NO178542 C NO 178542C
- Authority
- NO
- Norway
- Prior art keywords
- phaquinolinones
- benzo
- salt
- pharmaceutical formulation
- octahydrobenzo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/16—Preparation of ethers by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
- C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/562—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
- C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
- C07C49/792—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74811691A | 1991-08-21 | 1991-08-21 | |
US78103991A | 1991-10-21 | 1991-10-21 | |
US07/927,710 US5239075A (en) | 1991-08-21 | 1992-08-10 | Process for the preparation of benzo (f) quinolinones |
Publications (4)
Publication Number | Publication Date |
---|---|
NO923265D0 NO923265D0 (no) | 1992-08-20 |
NO923265L NO923265L (no) | 1993-02-22 |
NO178542B NO178542B (no) | 1996-01-08 |
NO178542C true NO178542C (no) | 1996-04-17 |
Family
ID=27419359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO923265A NO178542C (no) | 1991-08-21 | 1992-08-20 | Benzo[fÅkinolinoner, farmasöytisk formulering og salt derav |
Country Status (16)
Country | Link |
---|---|
US (6) | US5239075A (cs) |
EP (1) | EP0532190B1 (cs) |
JP (1) | JP3504678B2 (cs) |
KR (1) | KR100235562B1 (cs) |
CN (1) | CN1039320C (cs) |
CA (1) | CA2076479A1 (cs) |
CZ (1) | CZ290369B6 (cs) |
DE (1) | DE69231610T2 (cs) |
FI (1) | FI102475B1 (cs) |
HU (2) | HUT68034A (cs) |
IL (1) | IL102881A (cs) |
MX (1) | MX9204817A (cs) |
NO (1) | NO178542C (cs) |
NZ (1) | NZ244038A (cs) |
RU (1) | RU2126386C1 (cs) |
SG (1) | SG67312A1 (cs) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
GB9317314D0 (en) * | 1993-08-20 | 1993-10-06 | Smithkline Beecham Corp | Compounds |
US5574160A (en) * | 1994-05-26 | 1996-11-12 | Eli Lilly And Company | Syntheis of benzoquinolinones |
US5578724A (en) * | 1994-09-20 | 1996-11-26 | Eli Lilly And Company | Process for preparation of benzo[f]quinolinones |
US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
GB2294712B (en) * | 1994-11-01 | 1998-06-24 | Camco Drilling Group Ltd | Improvements in or relating to rotary drill bits |
TW450809B (en) * | 1995-03-21 | 2001-08-21 | Lilly Co Eli | Pharmaceutical compositions for preventing or treating prostatic cancer comprising benzoquinolin-3-one derivatives |
US5629007A (en) * | 1995-03-21 | 1997-05-13 | Eli Lilly And Company | Method of preventing prostatic cancer development |
US5635197A (en) * | 1995-03-21 | 1997-06-03 | Eli Lilly And Company | Treatment and prevention of prostatic cancer metastasis |
US5550134A (en) * | 1995-05-10 | 1996-08-27 | Eli Lilly And Company | Methods for inhibiting bone loss |
US6111110A (en) * | 1996-10-30 | 2000-08-29 | Eli Lilly And Company | Synthesis of benzo[f]quinolinones |
KR20000052952A (ko) * | 1996-10-30 | 2000-08-25 | 피터 지. 스트링거 | 벤조[에프]퀴놀리논의 합성 |
EP0926148A1 (en) * | 1997-12-23 | 1999-06-30 | Applied Research Systems Ars Holding N.V. | Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors |
CA2338298A1 (en) * | 1998-07-29 | 2000-02-10 | Merck & Co., Inc. | Tricyclic compounds |
JP2002531550A (ja) * | 1998-12-07 | 2002-09-24 | イーライ・リリー・アンド・カンパニー | 5α−還元酵素の阻害剤としてのベンゾキノリン−3−オン誘導体の結晶形 |
EP1135373A1 (en) * | 1998-12-07 | 2001-09-26 | Eli Lilly And Company | Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative |
GB0222516D0 (en) * | 2002-09-27 | 2002-11-06 | Karobio Ab | Novel compounds |
US9073920B2 (en) | 2010-08-17 | 2015-07-07 | Purdue Research Foundation | Substituted dibenzonaphthyridines, pharmaceutical uses thereof and processes therfor |
EP3523300A1 (en) | 2016-10-06 | 2019-08-14 | Assia Chemical Industries Ltd. | Solid state forms of valbenazine |
CN115504933A (zh) * | 2022-10-13 | 2022-12-23 | 广东工业大学 | 一种多取代喹啉酮化合物的制备方法及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4511569A (en) * | 1982-08-26 | 1985-04-16 | Schering Corporation | Tricyclic lactams and derivatives useful in increasing cardiac contractility |
SE8302361D0 (sv) * | 1983-04-27 | 1983-04-27 | Astra Laekemedel Ab | New tricyclic amines |
PH22879A (en) * | 1986-01-23 | 1989-01-19 | Hoffmann La Roche | Benzazecine derivatives |
ZA883034B (en) * | 1987-04-29 | 1989-03-29 | Smithkline Beckman Corp | Steroid 5-alpha-reductase inhibitors |
IN167395B (cs) * | 1987-07-21 | 1990-10-20 | Hoffmann La Roche | |
CA2011640A1 (en) * | 1989-03-20 | 1990-09-20 | Rene Imhof | Quinoline derivatives |
US5300294A (en) * | 1990-06-27 | 1994-04-05 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
US5250539A (en) * | 1991-08-21 | 1993-10-05 | Eli Lilly And Company | Hexahydrobenzo[f]quinolinones |
US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
-
1992
- 1992-08-10 US US07/927,710 patent/US5239075A/en not_active Expired - Fee Related
- 1992-08-19 HU HU9202711A patent/HUT68034A/hu unknown
- 1992-08-20 EP EP92307637A patent/EP0532190B1/en not_active Expired - Lifetime
- 1992-08-20 DE DE69231610T patent/DE69231610T2/de not_active Expired - Fee Related
- 1992-08-20 NO NO923265A patent/NO178542C/no unknown
- 1992-08-20 CA CA002076479A patent/CA2076479A1/en not_active Abandoned
- 1992-08-20 JP JP22136592A patent/JP3504678B2/ja not_active Expired - Fee Related
- 1992-08-20 FI FI923752A patent/FI102475B1/fi active
- 1992-08-20 KR KR1019920014992A patent/KR100235562B1/ko not_active IP Right Cessation
- 1992-08-20 SG SG1996003899A patent/SG67312A1/en unknown
- 1992-08-20 IL IL10288192A patent/IL102881A/en not_active IP Right Cessation
- 1992-08-20 CN CN92111068A patent/CN1039320C/zh not_active Expired - Fee Related
- 1992-08-20 RU SU5052860/04A patent/RU2126386C1/ru not_active IP Right Cessation
- 1992-08-20 CZ CS19922566A patent/CZ290369B6/cs not_active IP Right Cessation
- 1992-08-20 MX MX9204817A patent/MX9204817A/es not_active IP Right Cessation
- 1992-08-20 NZ NZ244038A patent/NZ244038A/en unknown
-
1993
- 1993-04-23 US US08/052,960 patent/US5334767A/en not_active Expired - Fee Related
-
1994
- 1994-04-06 US US08/223,884 patent/US5495021A/en not_active Expired - Fee Related
-
1995
- 1995-05-22 US US08/445,806 patent/US5541190A/en not_active Expired - Fee Related
- 1995-06-16 HU HU95P/P00235P patent/HU211338A9/hu unknown
-
1996
- 1996-04-17 US US08/633,990 patent/US5670512A/en not_active Expired - Fee Related
- 1996-07-17 US US08/683,750 patent/US5710163A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO178542B (no) | 1996-01-08 |
US5710163A (en) | 1998-01-20 |
EP0532190A2 (en) | 1993-03-17 |
FI923752A0 (fi) | 1992-08-20 |
JPH05239032A (ja) | 1993-09-17 |
RU2126386C1 (ru) | 1999-02-20 |
CA2076479A1 (en) | 1993-02-22 |
IL102881A (en) | 1999-12-31 |
KR100235562B1 (ko) | 1999-12-15 |
US5541190A (en) | 1996-07-30 |
FI923752A (fi) | 1993-02-22 |
US5670512A (en) | 1997-09-23 |
FI102475B (fi) | 1998-12-15 |
JP3504678B2 (ja) | 2004-03-08 |
NO923265L (no) | 1993-02-22 |
US5334767A (en) | 1994-08-02 |
US5239075A (en) | 1993-08-24 |
EP0532190A3 (en) | 1993-07-14 |
HUT68034A (en) | 1995-05-29 |
CN1039320C (zh) | 1998-07-29 |
FI102475B1 (fi) | 1998-12-15 |
DE69231610D1 (de) | 2001-02-01 |
IL102881A0 (en) | 1993-01-31 |
CN1071418A (zh) | 1993-04-28 |
EP0532190B1 (en) | 2000-12-27 |
HU211338A9 (en) | 1995-11-28 |
CZ290369B6 (cs) | 2002-07-17 |
NO923265D0 (no) | 1992-08-20 |
NZ244038A (en) | 1994-11-25 |
DE69231610T2 (de) | 2001-06-13 |
SG67312A1 (en) | 1999-09-21 |
MX9204817A (es) | 1993-04-01 |
KR930004268A (ko) | 1993-03-22 |
US5495021A (en) | 1996-02-27 |
CZ256692A3 (en) | 1993-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO178542C (no) | Benzo[fÅkinolinoner, farmasöytisk formulering og salt derav | |
IL97025A0 (en) | 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them | |
BR1100987A (pt) | Composto, composição farmacêutica da matéria, e, composição veterinária | |
NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
NO930950D0 (no) | Sammensetninger inneholdende kombinasjoner av overflateaktive midler og derivater av suksinske acyleringsmidler eller hydroksyaromatiske forbindelser og fremgangsmaater for anvendelse av disse | |
IL103875A0 (en) | Piperazinyl-and piperidinyl-cyclohexanol derivatives and pharmaceutical compositions containing the same | |
NO921835D0 (no) | Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav | |
MX9201356A (es) | Derivados de piperidina, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
AU2867992A (en) | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors | |
NO933524L (no) | Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav | |
IL82401A0 (en) | Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them | |
NO306903B1 (no) | 6-(substituert-metylen)-penem'er, farmasöytiske blandinger inneholdende slike, anvendelse derav og mellomprodukter for fremstilling av dem | |
MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
SE8600658D0 (sv) | Novel composition of matter | |
ITMI910456A1 (it) | Composizione farmaceutica per il trattamento della cataratta | |
ES2162856T3 (es) | Derivados de ergolina serotoninergicos. | |
TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
NO923266L (no) | Heksahydrobenzo(f)quinolinoner | |
ES2052670T3 (es) | Utilizacion de derivados de 2-pirimidinil-1-piperazina. | |
ES2062214T3 (es) | Derivados de aminooligohidroxi inhibidores de renina. | |
ITMI911445A0 (it) | Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva | |
DE69318418D1 (de) | Pharmazeutische zusammensetzungen, die 5-ht 1-rezeptoragonisten und absorptionsverstärker enthalten | |
ITMI911093A1 (it) | Composizione farmaceutica contenente un'associazione di 3, 4-di-o isobutirril-epinina ed isosorbide-5- monoidrato | |
IL119421A (en) | Pharmaceutical compositions comprising derivatives of phenylaminealkylamines or alkylenediamines |